Synthesis and characterization of Gelatin-functionalized Reduced Graphene Oxide for drug delivery application

Document Type : Original Research

Authors
F. S. Mostafavi
R. Imani
Amirkabir University of Technology
Abstract
Aims Using nanomaterials in cancer therapy has shown that this kind of treatment is more efficient with fewer side effects. A considerable number of nanomaterials that can be used in cancer therapy are introduced; among them, graphene attracts most of the scientist's attention due to its unique features. In this study, the graphene oxide (GO) was synthesized and reduced by gelatin for cellular delivery of an anticancer drug, curcumin, .

Materials and Methods GO was synthesized by hummer method and reduced by gelatin. Curcumin anticancer drug was loaded on the synthesized nanocarriers via hydrophobe-hydrophobe interaction.

Findings Chemical, physical and biological assays have been done to evaluate the synthesis and surface modification. In the next step, the drug loading efficiency was obtained by the UV-Vis spectroscopy method.

Conclusion: GO is successfully synthesized, with the average size of 300nm. AFM pictures of GO before and after reduction show an increase in thickness that proves the presence of gelatin on the surface. From the cytotoxicity assay on L292 cell line, it can be concluded that surface modification was effective because GO showed remarkable toxicity while gelatin-rGO does not show any toxicity even at a concentration of 200 μgml-1. Also, the drug loading efficiency is obtained at 78%. Therefore, the gelatin-rGO with excellent stability and biocompatibility can be suggested as a drug carrier applicable in biomedical studies.

Keywords

Subjects

1. Jemal, A., et al., Global cancer statistics. CA: a cancer journal for clinicians, 2011. 61(2): p. 69-90.
2. Song, S., et al., Biomedical application of graphene: From drug delivery, tumor therapy, to theranostics. Colloids and Surfaces B: Biointerfaces, 2020. 185: p. 110596.
3. Wang, L., M. Zheng, and Z. Xie, Nanoscale metal–organic frameworks for drug delivery: a conventional platform with new promise. Journal of Materials Chemistry B, 2018. 6(5): p. 707-717.
4. Brannon-Peppas, L. and J.O. Blanchette, Nanoparticle and targeted systems for cancer therapy. Advanced drug delivery reviews, 2012. 64: p. 206-212.
5. Yang, K., L. Feng, and Z. Liu, The advancing uses of nano-graphene in drug delivery. Expert opinion on drug delivery, 2015. 12(4): p. 601-612.
6. Nurunnabi, M., et al., Bioapplication of graphene oxide derivatives: drug/gene delivery, imaging, polymeric modification, toxicology, therapeutics and challenges. RSC advances, 2015. 5(52): p. 42141-42161.
7. Orecchioni, M., et al., Graphene as cancer theranostic tool: progress and future challenges. Theranostics, 2015. 5(7): p. 710.
8. Yang, K., L. Feng, and Z. Liu, Stimuli responsive drug delivery systems based on nano-graphene for cancer therapy. Advanced drug delivery reviews, 2016. 105: p. 228-241.
9. Rosenthal, A., et al., Biofunctionalization of titanium substrates using nanoscale polymer brushes with cell adhesion peptides. The Journal of Physical Chemistry B, 2018. 122(25): p. 6543-6550.
10. Liu, J., L. Cui, and D. Losic, Graphene and graphene oxide as new nanocarriers for drug delivery applications. Acta biomaterialia, 2013. 9(12): p. 9243-9257.
11. Zhang, X., et al., Preparation of thermo/pH-sensitive reduced graphene oxide interpenetrating hydrogel nanocomposites for co-delivery of paclitaxel and epirubicin. Materials technology, 2018. 33(4): p. 245-252.
12. Shan, C., et al., Water-soluble graphene covalently functionalized by biocompatible poly-L-lysine. Langmuir, 2009. 25(20): p. 12030-12033.
13. Zhang, L., et al., Functional graphene oxide as a nanocarrier for controlled loading and targeted delivery of mixed anticancer drugs. Small, 2010. 6(4): p. 537-544.
14. Stankovich, S., et al., Stable aqueous dispersions of graphitic nanoplatelets via the reduction of exfoliated graphite oxide in the presence of poly (sodium 4-styrenesulfonate). Journal of Materials Chemistry, 2006. 16(2): p. 155-158.
15. Feng, L., S. Zhang, and Z. Liu, Graphene based gene transfection. Nanoscale, 2011. 3(3): p. 1252-1257.
16. Yin, D., et al., Functional graphene oxide as a plasmid-based Stat3 siRNA carrier inhibits mouse malignant melanoma growth in vivo. Nanotechnology, 2013. 24(10): p. 105102.
17. Ege, D., A.R. Kamali, and A.R. Boccaccini, Graphene oxide/polymer‐based biomaterials. Advanced Engineering Materials, 2017. 19(12): p. 1700627.
18. Makharza, S., et al., Graphene oxide-gelatin nanohybrids as functional tools for enhanced carboplatin activity in neuroblastoma cells. Pharmaceutical research, 2015. 32(6): p. 2132-2143.
19. Shahriary, L. and A.A. Athawale, Graphene oxide synthesized by using modified hummers approach. Int. J. Renew. Energy Environ. Eng, 2014. 2(01): p. 58-63.
20. Fernandez-Fernandez, A., R. Manchanda, and A.J. McGoron, Theranostic applications of nanomaterials in cancer: drug delivery, image-guided therapy, and multifunctional platforms. Applied biochemistry and biotechnology, 2011. 165(7-8): p. 1628-1651.
21. An, J., et al., Synthesis of a biocompatible gelatin functionalized graphene nanosheets and its application for drug delivery. Materials Science and Engineering: C, 2013. 33(5): p. 2827-2837.
22. Lee, D.Y., et al., Blood compatible graphene/heparin conjugate through noncovalent chemistry. Biomacromolecules, 2011. 12(2): p. 336-341.
23. Zhou, Y., et al., Hydrothermal dehydration for the “green” reduction of exfoliated graphene oxide to graphene and demonstration of tunable optical limiting properties. Chemistry of Materials, 2009. 21(13): p. 2950-2956.
24. Imani, R., et al., Dual-functionalized graphene oxide for enhanced siRNA delivery to breast cancer cells. Colloids and Surfaces B: Biointerfaces, 2016. 147: p. 315-325.
25. Hu, K., et al., Core–shell biopolymer nanoparticle delivery systems: synthesis and characterization of curcumin fortified zein–pectin nanoparticles. Food chemistry, 2015. 182: p. 275-281.
26. Li, Q., et al., Curcumin–piperine mixtures in self-microemulsifying drug delivery system for ulcerative colitis therapy. International journal of pharmaceutics, 2015. 490(1-2): p. 22-31.
27. Aditya, N., et al., Co-delivery of hydrophobic curcumin and hydrophilic catechin by a water-in-oil-in-water double emulsion. Food chemistry, 2015. 173: p. 7-13.
28. Rao, K.M., et al., Curcumin encapsulated pH sensitive gelatin based interpenetrating polymeric network nanogels for anti cancer drug delivery. International journal of pharmaceutics, 2015. 478(2): p. 788-795.
29. Wang, Z., et al., Tuning the architecture of polymeric conjugate to mediate intracellular delivery of pleiotropic curcumin. European Journal of Pharmaceutics and Biopharmaceutics, 2015. 90: p. 53-62.
30. Some, S., et al., Cancer therapy using ultrahigh hydrophobic drug-loaded graphene derivatives. Scientific reports, 2014. 4: p. 6314.
31. Muthoosamy, K., et al., Exceedingly higher co-loading of curcumin and paclitaxel onto polymer-functionalized reduced graphene oxide for highly potent synergistic anticancer treatment. Scientific reports, 2016. 6: p. 32808.
32. Kundu, M., et al., pH-responsive and targeted delivery of curcumin via phenylboronic acid-functionalized ZnO nanoparticles for breast cancer therapy. Journal of advanced research, 2019. 18: p. 161-172.
33. Jose, A., et al., Effective skin cancer treatment by topical co-delivery of curcumin and STAT3 siRNA using cationic liposomes. AAPS PharmSciTech, 2018. 19(1): p. 166-175.
34. Manjili, H.K., et al., Pharmacokinetics and in vivo delivery of curcumin by copolymeric mPEG-PCL micelles. European Journal of Pharmaceutics and Biopharmaceutics, 2017. 116: p. 17-30.
Pathobiology Reserach
Volume 23, Issue 5
April 2021
Pages 75-85